PHOTON Posted on September 28, 2020 A Randomized, Double-Masked, Active-Controlled Phase 2/3 Study of the Efficacy and Safety of High-Dose Aflibercept in Patients with Diabetic Macular Edema (PHOTON) Sponsor: Regeneron Pharmaceuticals CLINICALTRIALS.GOV